Greenland Mines Ltd (GRML) stock
GRMLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as GRMLW
$2.99+0.08 (+2.75%)
Close on Nov 20, 2026Market cap $40.92MP/E –Yield –
Greenland Mines operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Greenland Mines's operating cash flow for the twelve months ending Sep 30, 2026 was -$23.51M. For fiscal 2025 it was -$5.89M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.89M | – |
| FY2024 | Dec 31, 2024 | -$2.95M | – |
| FY2023 | Dec 31, 2023 | -$446.92K | – |
| FY2022 | Dec 31, 2022 | -$493.04K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$10.41M | – |
| Q2 FY2026 | Jun 30, 2026 | -$6.85M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.28M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$944.15K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.07M | -6053.3% |
| Q2 FY2024 | Jun 30, 2024 | -$907.42K | -943.7% |
| Q1 FY2024 | Mar 31, 2024 | -$21.98K | – |
| Q4 FY2023 | Dec 31, 2023 | -$199.51K | – |
| Q3 FY2023 | Sep 30, 2023 | $18.02K | – |
| Q2 FY2023 | Jun 30, 2023 | $107.55K | – |
| Q1 FY2023 | Mar 31, 2023 | -$372.98K | -6029.7% |
| Q4 FY2022 | Dec 31, 2022 | -$73.18K | – |
| Q3 FY2022 | Sep 30, 2022 | -$33.24K | – |
| Q2 FY2022 | Jun 30, 2022 | -$392.91K | – |
| Q1 FY2022 | Mar 31, 2022 | $6.29K | – |
See a number that looks wrong?